35 related articles for article (PubMed ID: 23689000)
1. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
[TBL] [Abstract][Full Text] [Related]
2. Stromal or intraepithelial tumor-infiltrating lymphocytes: which one has more prognostic significance in cervical cancer?
Gultekin M; Beduk Esen CS; Ates Ozdemir D; Yildirim S; Yuce D; Usubutun A; Yildiz F
Arch Gynecol Obstet; 2023 Mar; 307(3):969-980. PubMed ID: 35840843
[TBL] [Abstract][Full Text] [Related]
3. TILs Immunophenotype in Breast Cancer Predicts Local Failure and Overall Survival: Analysis in a Large Radiotherapy Trial with Long-Term Follow-Up.
Millar E; Browne L; Slapetova I; Shang F; Ren Y; Bradshaw R; Ann Brauer H; O'Toole S; Beretov J; Whan R; Graham PH
Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32825588
[TBL] [Abstract][Full Text] [Related]
4. CD3 and CD20 Expressions and Infiltrating Patterns in Salivary Gland Tumors.
Hussein RR; Garib BT
Diagnostics (Basel); 2024 May; 14(9):. PubMed ID: 38732373
[TBL] [Abstract][Full Text] [Related]
5. CD20
Qin LJ; Xu H; Li LP; Li SH; Xu SY; Chen K; Yang T; Wang FH; Zuo L; Zeng L; Wang HY
Heliyon; 2024 May; 10(9):e30901. PubMed ID: 38774103
[TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis.
Qin Y; Peng F; Ai L; Mu S; Li Y; Yang C; Hu Y
Cancer Cell Int; 2021 Jun; 21(1):310. PubMed ID: 34118931
[TBL] [Abstract][Full Text] [Related]
7. The Role of Tumor-Infiltrating B Cells in Tumor Immunity.
Guo FF; Cui JW
J Oncol; 2019; 2019():2592419. PubMed ID: 31662750
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of tumour-infiltrating B cells and tertiary lymphoid structures: a novel anti-cancer treatment avenue?
Siliņa K; Rulle U; Kalniņa Z; Linē A
Cancer Immunol Immunother; 2014 Jul; 63(7):643-62. PubMed ID: 24695950
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.
Ibrahim EM; Al-Foheidi ME; Al-Mansour MM; Kazkaz GA
Breast Cancer Res Treat; 2014 Dec; 148(3):467-76. PubMed ID: 25361613
[TBL] [Abstract][Full Text] [Related]
10. The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis.
Mao Y; Qu Q; Chen X; Huang O; Wu J; Shen K
PLoS One; 2016; 11(4):e0152500. PubMed ID: 27073890
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic value of B lymphocyte infiltration in breast cancer].
Yu H; Yang J; Jiao S; Wang J
Nan Fang Yi Ke Da Xue Xue Bao; 2013 May; 33(5):750-5. PubMed ID: 23689000
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of T lymphocytes infiltration in breast cancer].
Yu HM; Jiao SC; Yang JL; Wang JD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Apr; 35(2):199-206. PubMed ID: 23643010
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Implications of Tumor-Infiltrating Lymphocytes in Association With Programmed Death Ligand 1 Expression in Early-Stage Breast Cancer.
Park IH; Kong SY; Ro JY; Kwon Y; Kang JH; Mo HJ; Jung SY; Lee S; Lee KS; Kang HS; Lee E; Joo J; Ro J
Clin Breast Cancer; 2016 Feb; 16(1):51-8. PubMed ID: 26364145
[TBL] [Abstract][Full Text] [Related]
14. The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.
Arias-Pulido H; Cimino-Mathews A; Chaher N; Qualls C; Joste N; Colpaert C; Marotti JD; Foisey M; Prossnitz ER; Emens LA; Fiering S
Breast Cancer Res Treat; 2018 Sep; 171(2):273-282. PubMed ID: 29858752
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy.
Bai YG; Gao GX; Zhang H; Zhang S; Liu YH; Duan XN; Xu L
Chin Med J (Engl); 2020 Mar; 133(5):552-560. PubMed ID: 32044815
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
